Patients' adherence to recommended follow-up eye care after diabetic retinopathy screening in a publicly funded county clinic and factors associated with follow-up eye care use

JAMA Ophthalmology

Volumn 134, Issue 11, 2016, Pages 1221-1228

  Keenum, Zachary ^a   McGwin, Gerald ^b   Witherspoon, C Douglas ^a   Haller, Julia A ^c   Clark, Mark E ^a   Owsley, Cynthia ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; DIABETIC RETINOPATHY; DISEASE DURATION; EYE CARE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VISUAL IMPAIRMENT; ALABAMA; BLINDNESS; COMPLICATION; DIABETES MELLITUS, TYPE 2; DISEASE COURSE; MASS SCREENING; MIDDLE AGED; OUTPATIENT DEPARTMENT; PATIENT CARE; PREVALENCE; PROCEDURES; PROGNOSIS; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALABAMA; AMBULATORY CARE FACILITIES; BLINDNESS; CONTINUITY OF PATIENT CARE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84997161559     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2016.3081     Document Type: Article

References (41)

1. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2014: Estimates of Diabetes and Its Burden in the United States. Atlanta, GA: US Dept of Health and Human Services; 2014. http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed April 24, 2016.
2. Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care. 2001;24(11): 1936-1940.
3. Saaddine JB, Honeycutt AA, Narayan KM, Zhang X, Klein R, Boyle JP. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol. 2008;126(12): 1740-1747.
4. Klein R, Klein BEK. Vision disorders in diabetes. In: Harris M, ed. Diabetes in America. Washington, DC: US Government Printing Office; 1995. National Institutes of Health publication 95-1468.
5. American Diabetes Association. Standards of medical care in diabetes: 2014. Diabetes Care. 2014; 37(suppl 1):S14-S80.
6. American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern Guideline: diabetic retinopathy. http://www.aao.org/preferred-practice-pattern/diabetic-retinopathy-ppp-updated-2016. Updated 2016. Accessed April 24, 2016.
7. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002;136(8):565-574.
8. Maclennan PA, McGwin G Jr, Heckemeyer C, et al. Eye care use among a high-risk diabetic population seen in a public hospital's clinics. JAMA Ophthalmol. 2014;132(2):162-167.
9. Anderson RM, Wolf FM, Musch DC, et al. Conducting community-based, culturally specific, eye disease screening clinics for urban African Americans with diabetes. Ethn Dis. 2002;12(3): 404-410.
10. Owsley C, McGwin G, Scilley K, Girkin CA, Phillips JM, Searcey K. Perceived barriers to care and attitudes about vision and eye care: focus groups with older African Americans and eye care providers. Invest Ophthalmol Vis Sci. 2006;47(7): 2797-2802.
11. Maclennan PA, McGwin G Jr, Searcey K, Owsley C. A survey of Alabama eye care providers in 2010-2011. BMC Ophthalmol. 2014;14:44.
12. Rask KJ, Williams MV, Parker RM, McNagny SE. Obstacles predicting lack of a regular provider and delays in seeking care for patients at an urban public hospital. JAMA. 1994;271(24):1931-1933.
13. Chou CF, Sherrod CE, Zhang X, et al. Barriers to eye care among people aged 40 years and older with diagnosed diabetes, 2006-2010. Diabetes Care. 2014;37(1):180-188.
14. Chin MH, Zhang JX, Merrell K. Diabetes in the African-American Medicare population: morbidity, quality of care, and resource utilization. Diabetes Care. 1998;21(7):1090-1095.
15. Halanych JH, Wang F, Miller DR, et al. Racial/ethnic differences in diabetes care for older veterans: accounting for dual health system use changes conclusions. Med Care. 2006;44(5): 439-445.
16. Peek ME, Cargill A, Huang ES. Diabetes health disparities: a systematic review of health care interventions. Med Care Res Rev. 2007;64(5) (suppl):101S-156S.
17. Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304(6):649-656.
18. Forster AS, Forbes A, Dodhia H, et al. Changes in detection of retinopathy in type 2 diabetes in the first 4 years of a population-based diabetic eye screening program: retrospective cohort study. Diabetes Care. 2013;36(9):2663-2669.
19. Garg S, Jani PD, Kshirsagar AV, King B, Chaum E. Telemedicine and retinal imaging for improving diabetic retinopathy evaluation. Arch Intern Med. 2012;172(21):1677-1678.
20. Kirkizlar E, Serban N, Sisson JA, Swann JL, Barnes CS, Williams MD. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration. Ophthalmology. 2013;120(12):2604-2610.
21. Mansberger SL, Sheppler C, Barker G, et al. Long-term comparative effectiveness of telemedicine in providing diabetic retinopathy screening examinations: a randomized clinical trial. JAMA Ophthalmol. 2015;133(5):518-525.
22. Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol. 2002;134(2):204-213.
23. Bragge P, Gruen RL, Chau M, Forbes A, Taylor HR. Screening for presence or absence of diabetic retinopathy: ameta-analysis. Arch Ophthalmol. 2011;129(4):435-444.
24. Zimmer-Galler IE, Zeimer R. Telemedicine in diabetic retinopathy screening. Int Ophthalmol Clin. 2009;49(2):75-86.
25. Silva PS, Cavallerano JD, Aiello LM, Aiello LP. Telemedicine and diabetic retinopathy: moving beyond retinal screening. Arch Ophthalmol. 2011; 129(2):236-242.
26. Wilson RR, Silowash R, Anthony L, Cecil RA, Eller A. Telemedicine process used to implement an effective and functional screening program for diabetic retinopathy. J Diabetes Sci Technol. 2008;2 (5):785-791.
27. Mansberger SL, Gleitsmann K, Gardiner S, et al. Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: a randomized controlled trial. Telemed J E Health. 2013;19(12): 942-948.
28. Li HK, Horton M, Bursell SE, et al; American Telemedicine Association Diabetic Retinopathy Telehealth Practice Recommendations Working Group. Telehealth Practice Recommendations for Diabetic Retinopathy, Second Edition. Telemed J E Health. 2011;17(10):814-837.
29. Owsley C, McGwin G Jr, Lee DJ, et al; Innovative Network for Sight (INSIGHT) Research Group. Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine. JAMA Ophthalmol. 2015;133(2): 174-181.
30. Harding S, Greenwood R, Aldington S, et al; Diabetic Retinopathy Grading and Disease Management Working Party. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med. 2003;20(12):965-971.
31. Feder RS, Olsen TW, Prum BE Jr, et al. Comprehensive adult medical eye evaluation Preferred Practice Pattern guidelines. Ophthalmology. 2016;123(1):209-236.
32. Sheppler CR, Lambert WE, Gardiner SK, Becker TM, Mansberger SL. Predicting adherence to diabetic eye examinations: development of the Compliance With Annual Diabetic Eye Exams Survey. Ophthalmology. 2014;121(6):1212-1219.
33. Pasagian-Macaulay A, Basch CE, Zybert P, Wylie-Rosett J. Ophthalmic knowledge and beliefs among women with diabetes. Diabetes Educ. 1997; 23(4):433-437.
34. Walker EA, Basch CE, Howard CJ, Zybert PA, Kromholz WN, Shamoon H. Incentives and barriers to retinopathy screening among African-Americans with diabetes. J Diabetes Complications. 1997;11 (5):298-306.
35. Javitt JC. Preventing blindness in Americans: the need for eye health education. Surv Ophthalmol. 1995;40(1):41-44.
36. Hartnett ME, Key IJ, Loyacano NM, Horswell RL, Desalvo KB. Perceived barriers to diabetic eye care: qualitative study of patients and physicians. Arch Ophthalmol. 2005;123(3):387-391.
37. Basch CE, Walker EA, Howard CJ, Shamoon H, Zybert P. The effect of health education on the rate of ophthalmic examinations among African Americans with diabetes mellitus. Am J Public Health. 1999;89(12):1878-1882.
38. Nathan DM; DCCT/EDIC Research Group. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study at 30 years: overview. Diabetes Care. 2014;37(1):9-16.
39. Rickheim PL, Weaver TW, Flader JL, Kendall DM. Assessment of group versus individual diabetes education: a randomized study. Diabetes Care. 2002;25(2):269-274.
40. Paz SH, Varma R, Klein R, Wu J, Azen SP; Los Angeles Latino Eye Study Group. Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study. Ophthalmology. 2006; 113(8):1372-1377.
41. Schoenfeld ER, Greene JM, Wu SY, Leske MC. Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology. 2001;108(3):563-571.